cash flows from operating activities
profit for the year
6143026
4 333 300
depreciation
1577042
1 413 323
amortisation
122176
110 450
gain from the sale of property plant and equipment
-2162
-6 674
write-off of property plant and equipment
27189
7 229
impairment of trade and other receivables
-
22 308
finance income
-93683
-248 582
finance expenses -excluding impairment
517714
506 279
impairment of trade and other receivables
31647
30 959
net foreign exchange transactions loss / -gain
8017
-122 532
income tax expense
15242
4 774
increase in inventories
-190884
-253 915
increase in trade and other receivables
-7912
-523 507
increase in trade and other payables
276341
771 055
increase in contract liabilities
80278
480 384
cash flows from operations
8504031
6 524 851
net cash flows from operating activities
8499396
6 515 413
cash flows from investing activities
acquisition/construction of property plant and equipment
-3734757
-3 778 215
proceeds from sale of property plant and equipment
2724
13 092
acquisition of intangible assets
-55466
-126 234
proceeds from government grant
-
139 182
placing short-term bank deposits
-866831
-2 097 704
proceeds from short-term bank deposits return
1648623
1 858 475
bank interest received
93683
110 796
loans returned from third parties
-
1 000
net cash flows used in investing activities
-2912024
-3 879 608
the notes on pages 24 to 57 are an integral part of these consolidated financial statements
md medical group investments plc consolidated statement of cash flows -continued
for the year ended 31 december 2021
cash flows from financing activities
proceeds from loans and borrowings
-
1 193 493
repayment of loans and borrowings
-1490806
-1 319 275
payments of lease liabilities
-152470
-158 086
finance expenses paid
-363727
-375 047
proceeds from reimbursed vat
33138
337 378
repayment of reimbursed vat
-152123
-111 351
dividends paid to the owners of the company
-2726685
-2 211 202
dividends paid to non-controlling interests
-178177
-134 823
net cash flows used in financing activities
-5030850
-2 778 913
net increase / -decrease in cash and cash equivalents
556522
-143 108
cash and cash equivalents as at the beginning of the year 16
3128718
3 061 448
effect of movements in exchange rates on cash held
-95617
210 378
cash and cash equivalents as at the end of the year
3589623
3 128 718